Hong Kong’s CR-CP Life Science Fund Leads $22M Series C2 Round In US Biotech Firm

For Digital Subscribers Only

American biopharmaceutical firm Sirnaomics Inc. has raised US$22 million in a series C2 round of financing led by CR-CP Life Sciences Fund, a Hong Kong-based joint venture between Asian conglomerates China Resources Group and Charoen Pokphand Group, according to a statement released on Saturday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

RELATED NEWS



LEAVE A REPLY